Electroacupuncture (EA) analgesia in neuropathic pain is frequency-dependent: classical work established that 2 Hz and 100 Hz stimulation act through spinal endogenous opioid release, while the source study (Fang, Cheng and Yu 2024) showed in sciatic-nerve-cuffing mice that 18 kHz kilohertz high-frequency electroacupuncture stimulation (KHES) produces superior and prolonged analgesia that, unlike 2 Hz and 100 Hz, does not involve neuropeptide release and is instead associated with a spinal serotonergic signature (5-HT receptor, GIRK potassium-channel, and Cav2.2 calcium-channel transcript changes). The serotonergic mechanism was advanced only as a hypothesis, and the study itself flagged three gaps: unexplored frequency space and pain models, a comparison window limited to 7 days, and the untested 5-HT-mediated mechanism of KHES. A 2025 follow-up by the same group causally validated only the downstream CaMKII/NMDAR2B excitability arm in a different model (chronic constriction injury). The open problem is to deliver a causal, frequency-resolved mechanistic account of EA analgesia in neuropathic pain — testing whether KHES analgesia requires descending 5-HT signaling acting through 5-HT1-family receptors, GIRK channels, and Cav2.2 suppression — and to establish how analgesic efficacy and durability vary across the EA frequency spectrum, pain models, and longer time horizons, so that stimulation frequency can be rationally selected.

Background

Neuropathic pain — chronic pain arising from nerve injury — is difficult to treat with drugs, and electroacupuncture (EA, electrical stimulation delivered through acupuncture needles) is widely studied as a non-pharmacological alternative. A standard rodent model is sciatic nerve cuffing, in which a tight cuff placed around the sciatic nerve produces lasting mechanical allodynia (pain from normally innocuous touch, measured by paw-withdrawal thresholds to filaments) and thermal hyperalgesia (exaggerated responses to heat). EA analgesia depends strongly on stimulation frequency. Classical work by Han and colleagues showed that low-frequency (2 Hz) EA drives spinal release of endorphin and enkephalin acting at mu/delta opioid receptors, whereas high-frequency (100 Hz) EA drives release of dynorphin acting at kappa receptors, establishing frequency-specific opioid mediation (e.g. Chen and Han 1992). Frequencies in the 1–100 kHz range, termed kilohertz high-frequency electroacupuncture stimulation (KHES), were originally shown to block peripheral nerve conduction without nerve damage (Ling et al. 2019), and kHz-frequency stimulation is already used clinically as spinal-cord stimulation for neuropathic pain. The source study (Fang, Cheng and Yu 2024, Journal of Molecular Neuroscience 74:98) compared 2 Hz, 100 Hz, and 18 kHz EA in sciatic-nerve-cuffing mice. It found that all three frequencies suppressed spinal inflammatory cytokines (IL-1beta, TNF-alpha), that 2 Hz and 100 Hz acted through the established opioid-peptide mechanism, but that 18 kHz EA — which gave the most persistent analgesia over a 7-day repeated-stimulation course (behavioral follow-up to day 13) — did not change spinal neuropeptide levels. Spinal RNA sequencing (transcriptome profiling) and quantitative RT-PCR in the 18 kHz group instead showed changes consistent with serotonergic modulation: increased 5-HT1A and GIRK (G protein-gated inwardly rectifying potassium channel, which hyperpolarizes neurons) transcripts, and decreased 5-HT2A/5-HT2B, Cav2.2 (the N-type voltage-gated calcium channel that drives neurotransmitter release and neuronal excitability), CaMKII (calcium/calmodulin-dependent protein kinase II), and NMDAR2B (a subunit of the N-methyl-D-aspartate glutamate receptor central to central sensitization) transcripts. Serotonin (5-HT) released by descending projections from brainstem raphe neurons modulates dorsal-horn pain processing through these receptor and channel targets. On this basis the authors advanced a scientific hypothesis — as yet untested — that KHES augments descending 5-HT projection and release, that upregulated 5-HT1 receptors coupled to GIRK activation and reduced Cav2.2 opening dampen spinal neuron excitability, and that downregulated 5-HT2 receptors curb spinal glial activation. The paper's discussion explicitly lists what remains open: additional frequencies and other pain types, longer-term comparison beyond 7 days, and mechanistic dissection of KHES through 5-HT receptor subtypes, synaptic plasticity, and downstream neuroglia. Note that the opioid mechanism for 2 Hz/100 Hz EA is classical established knowledge; the unresolved causal question concerns kilohertz-frequency stimulation.

Causal validation of this hypothesis, in contrast to the correlational transcriptomic evidence, is approached in this literature through loss- and gain-of-function manipulation of the pathway — pharmacological or genetic blockade of descending 5-HT signaling, 5-HT1-family and 5-HT2-family receptor manipulation, GIRK and Cav2.2 channel blockade, and glial-inhibition controls — read out behaviorally as rescue or enhancement of analgesia.

Problem Statement

Establish a causal, frequency-resolved account of electroacupuncture analgesia in neuropathic pain, sufficient to justify rational frequency selection clinically. The overarching objective ties together three jointly necessary components, all drawn from the source study's own open questions. (1) Causal mechanism of kilohertz stimulation: determine whether the superior and prolonged analgesia produced by 18 kHz KHES in neuropathic pain causally requires the spinal serotonergic pathway (descending 5-HT signaling acting through 5-HT1-family receptors, GIRK channels, and Cav2.2 suppression), as hypothesized — and determine how this relates to the already-validated downstream CaMKII/NMDAR2B cascade and to residual peripheral nerve-conduction block; distinguish causal necessity from the correlational transcriptomic evidence, and identify the cellular locus of the observed spinal molecular changes — which neuronal and glial cell types, and which descending projections, carry the 18 kHz effect — since without this the mechanistic account remains correlational at tissue level. (2) Frequency generalization: determine how analgesic efficacy and the underlying molecular profile vary across a broader frequency space (other kilohertz and intermediate frequencies, different pulse parameters) and across other pain models (e.g. inflammatory pain, diabetic neuropathy, chemotherapy-induced neuropathy, and other surgical neuropathies), relative to the 2 Hz / 100 Hz / 18 kHz profile established in the sciatic-nerve-cuffing model. (3) Long-term durability: establish whether the frequency groups differ in analgesic durability, tolerance, or plasticity beyond the 7-day repeated-stimulation window already studied. A mechanistically validated, frequency-specific account of EA analgesia in neuropathic pain — rather than additional behavioral or transcriptomic correlations — requires components (2) and (3) to rest on a principled sample across the frequency space, pulse parameters, and pain models, with follow-up beyond the 7-day window, that discriminates the frequency-specific mechanisms (serotonergic, opioid, and conduction-block contributions) from one another; exhaustive coverage of the frequency or model space is not required.

References

  1. Fang Kexin, Cheng Wen, Yu Bin (2024). Effects of Electroacupuncture at Varied Frequencies on Analgesia and Mechanisms in Sciatic Nerve Cuffing-Induced Neuropathic Pain Mice. Journal of Molecular Neuroscience 74(4):98. DOI 10.1007/s12031-024-02276-6. https://doi.org/10.1007/s12031-024-02276-6
  2. Fang Kexin, Ouyang Xiaorong, Cheng Wen, Yu Bin (2025). Kilohertz High-Frequency Electrical Stimulation Effectively Mitigates Hyperalgesia in Mice With Neuropathic Pain Through Regulation of the Calcium/Calmodulin-Dependent Protein Kinase II/N-Methyl-D-Aspartate 2B Signaling Pathway. Neuromodulation 28(6):962-975. DOI 10.1016/j.neurom.2025.03.071. https://doi.org/10.1016/j.neurom.2025.03.071
  3. Fang Kexin, Lu Peixin, Cheng Wen, Yu Bin (2024). Kilohertz high-frequency electrical stimulation ameliorate hyperalgesia by modulating transient receptor potential vanilloid-1 and N-methyl-D-aspartate receptor-2B signaling pathways in chronic constriction injury of sciatic nerve mice. Molecular Pain 20:17448069231225810. DOI 10.1177/17448069231225810. https://doi.org/10.1177/17448069231225810
  4. Qi Pengfei, Li Quan, Han Mingyuan, Cui Yang, Zhou Xinyu, Sun Zhongren, Ding Shuo, Yu Mengdi, Zhang Hongbo, Yin Hongna (2025). The analgesic mechanism of electroacupuncture at the central level for neuropathic pain: a review of studies based on animal experiments. Frontiers in Neurology 16:1587471. DOI 10.3389/fneur.2025.1587471. https://doi.org/10.3389/fneur.2025.1587471
  5. Weng Rui-Xia, Gao Yuan, Zhang Chen-Hao, Yan Ru-Yu, Liu Qi, Xu Zhen-Hua, Wang Hua-Zheng, Li Rui, Gao Rong, Li Yong-Chang, Xu Guang-Yin (2026). The enhanced analgesic effects of electroacupuncture and repetitive transcranial magnetic stimulation on visceral pain via ventral lateral septal nucleus. Molecular Pain 22:17448069261428970. DOI 10.1177/17448069261428970. https://doi.org/10.1177/17448069261428970
  6. Chen Xiao-Hong, Han Ji-Sheng (1992). Analgesia induced by electroacupuncture of different frequencies is mediated by different types of opioid receptors: another cross-tolerance study. Behavioural Brain Research 47(2):143-149. DOI 10.1016/s0166-4328(05)80120-2. https://doi.org/10.1016/s0166-4328(05)80120-2
  7. Ling Dandan, Luo Junjie, Wang Mengying, Cao Xiaodan, Chen Xiaorui, Fang Kexin, Yu Bin (2019). Kilohertz high-frequency alternating current blocks nerve conduction without causing nerve damage in rats. Annals of Translational Medicine 7(22):661. DOI 10.21037/atm.2019.10.36. https://doi.org/10.21037/atm.2019.10.36
  8. Chen Nisang, Xu Moran, Wang Junyi, Wang Dong, Luo Kaitao, Hao Ya-Bo, Chen Kun, Yang Xibing, Ren Hongbin, Fang Jianqiao, Wu Yuanyuan (2026). Effect of Electroacupuncture for Trigeminal Neuralgia: Study Protocol for a Multicenter Randomized Controlled Trial. Journal of Pain Research 19:1-14. DOI 10.2147/JPR.S616735. https://doi.org/10.2147/JPR.S616735
  9. Chen Zhaoyue, Lu Chuchu, Yang Linqi, Song Yaqing, Jia Chaoyi, Zhang Haowen, Yu Cheng, Zhang Lili (2026). Research Advances in Acupuncture Treatment for Chronic Pain. Pain Management Nursing. DOI 10.1016/j.pmn.2026.04.021. https://doi.org/10.1016/j.pmn.2026.04.021
  10. Liang Xiaoying, Xiao Shuting, Gong Yuhan, Wu Shaoxian, Chen Yao, Zhang Chun, He Rongyan (2026). Advances in needle-based interventions for chronic neuropathic pain. European Journal of Pharmaceutics and Biopharmaceutics 227:115214. DOI 10.1016/j.ejpb.2026.115214. https://doi.org/10.1016/j.ejpb.2026.115214